Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 106
Filter
Add more filters










Publication year range
1.
Andrologia ; 50(2)2018 Mar.
Article in English | MEDLINE | ID: mdl-28730645

ABSTRACT

The study was designed to evaluate the effects of metformin on apoptosis and epididymal sperm quality in a rat testicular ischaemia/reperfusion (I/R) injury model. A total of 72 male rats were divided into four groups (n = 18 for each group): group 1 (sham-operated group), group 2 (metformin group), group 3 (torsion/detorsion [T/D] + saline) and group 4 (T/D + 300 mg kg-1 metformin). Testicular torsion was achieved by rotating the right testis 720° in a clockwise direction for 1 hr. Tissue malondialdehyde (MDA) level and caspase-3 activity increased and the activities of catalase, superoxide dismutase and glutathione peroxidase decreased in comparison with sham-operated group 4 hr after detorsion (p < .001). In six rats of each group 24 hr after detorsion, histopathological changes and germ cell apoptosis were significantly deteriorated by measuring mean of seminiferous tubule diameters (MSTD) and TUNEL test. Moreover, 30 days after T/D, sperm concentration and motility were examined in six animals per group. Metformin pre-treatment reduced MDA and caspase-3 levels and normalised antioxidant enzyme activities 4 hr after detorsion, and germ cell apoptosis was significantly decreased, and the MSTD, as well as sperm functions, was significantly improved. Reduction in oxidative stress and apoptosis may have a major role in cytoprotective effects of metformin.


Subject(s)
Apoptosis/drug effects , Enzyme Activators/pharmacology , Metformin/pharmacology , Reperfusion Injury/physiopathology , Spermatozoa/physiology , AMP-Activated Protein Kinases/metabolism , Animals , Caspase 3/metabolism , Catalase/metabolism , Disease Models, Animal , Enzyme Activators/therapeutic use , Epididymis/cytology , Epididymis/drug effects , Epididymis/pathology , Humans , In Situ Nick-End Labeling , Male , Malondialdehyde/metabolism , Metformin/therapeutic use , Oxidative Stress/drug effects , Rats , Rats, Wistar , Reperfusion Injury/drug therapy , Reperfusion Injury/etiology , Sperm Count , Spermatic Cord Torsion/complications , Spermatozoa/drug effects , Testis/pathology
2.
Andrologia ; 49(2)2017 Mar.
Article in English | MEDLINE | ID: mdl-27147301

ABSTRACT

We designed this experiment to evaluate the effects of nortriptyline on testicular injury after torsion/detorsion (T/D). Ninety-six adult Wistar rats were divided into six groups 16 each in control group (Group 1), sham operated (Group 2), T/D + saline (Group 3), and in groups 4-6; were administered 2, 10 and 20 mg kg-1 , i.p. of nortriptyline 30 and 90 min after torsion respectively. Testicular torsion was created by twisting the right testis 720° in clockwise direction for 1 h. In six rats of each group, tissue MDA level and caspase-3 activity increased and the activities of catalase, superoxide dismutase and glutathione peroxidase decreased in compared with control group 4 h after detorsion (P < 0.001). In six rats of each group 24 h after detorsion, histopathological changes and germ cell apoptosis were significantly deteriorated by measuring mean of seminiferous tubules diameters (MSTD) and TUNEL test. Moreover, 30 days after T/D, sperm concentration and motility were examined in rest of rats. Pre- and post-reperfusion nortriptyline could reduce MDA and caspase-3 levels and normalise antioxidant enzymes activities, dose dependently. Germ cell apoptosis was significantly decreased, and the MSTD, as well as sperm functions, were significantly improved. Inhibition of mitochondrial permeability transition pore is probably involved in protective effects of nortriptyline against testicular T/D cell damages.


Subject(s)
Adrenergic Uptake Inhibitors/pharmacology , Apoptosis/drug effects , Cytoprotection , Nortriptyline/pharmacology , Oxidative Stress/drug effects , Reperfusion Injury/prevention & control , Spermatic Cord Torsion/complications , Spermatozoa/drug effects , Testis/drug effects , Adrenergic Uptake Inhibitors/administration & dosage , Animals , Caspase 3/metabolism , Catalase/metabolism , Disease Models, Animal , Glutathione Peroxidase/metabolism , Humans , In Situ Nick-End Labeling , Male , Malondialdehyde/metabolism , Nortriptyline/administration & dosage , Rats , Rats, Wistar , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Sperm Count , Spermatic Cord Torsion/pathology , Spermatozoa/pathology , Superoxide Dismutase/metabolism , Testis/blood supply , Testis/pathology
3.
Neuroscience ; 315: 271-85, 2016 Feb 19.
Article in English | MEDLINE | ID: mdl-26708749

ABSTRACT

The neuroimmune-endocrine dysfunction has been accepted as one of fundamental mechanisms contributing to the pathophysiology of psychiatric disorders including depression and anxiety. In this study, we aimed to evaluate the involvement of hypothalamic-pituitary-adrenal (HPA) axis, interleukin-1ß, and nitrergic system in mediating the negative behavioral impacts of juvenile social isolation stress (SIS) in male mice. We also investigated the possible protective effects of lithium on behavioral and neurochemical changes in socially isolated animals. Results showed that experiencing 4-weeks of juvenile SIS provoked depressive and anxiety-like behaviors that were associated with hyper responsiveness of HPA axis, upregulation of interleukin-1ß, and nitric oxide (NO) overproduction in the pre-frontal cortex and hippocampus. Administration of lithium (10 mg/kg) significantly attenuated the depressant and anxiogenic effects of SIS in behavioral tests. Lithium also restored the negative effects of SIS on cortical and hippocampal interleukin-1ß and NO as well as HPA axis deregulation. Unlike the neutralizing effects of l-arginine (NO precursor), administration of l-NAME (3 mg/kg) and aminoguanidine (20 mg/kg) potentiated the positive effects of lithium on the behavioral and neurochemical profile of isolated mice. In conclusion, our results revealed that juvenile SIS-induced behavioral deficits are associated with abnormalities in HPA-immune function. Also, we suggest that alleviating effects of lithium on behavioral profile of isolated mice may be partly mediated by mitigating the negative impact of NO on HPA-immune function.


Subject(s)
Anti-Anxiety Agents/pharmacology , Antidepressive Agents/pharmacology , Anxiety Disorders/drug therapy , Depressive Disorder/drug therapy , Lithium Compounds/pharmacology , Animals , Anxiety Disorders/physiopathology , Corticosterone/blood , Depressive Disorder/physiopathology , Disease Models, Animal , Dose-Response Relationship, Drug , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/growth & development , Hypothalamo-Hypophyseal System/metabolism , Interleukin-1beta/metabolism , Male , Mice , Motor Activity/drug effects , Nitric Oxide/metabolism , Nitrites/metabolism , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/growth & development , Pituitary-Adrenal System/metabolism , Social Isolation , Stress, Psychological/drug therapy , Stress, Psychological/physiopathology
4.
Neuroscience ; 306: 1-9, 2015 Oct 15.
Article in English | MEDLINE | ID: mdl-26272534

ABSTRACT

Learning and memory impairment is one of the most challenging complications of cirrhosis and present treatments are unsatisfactory. The exact mechanism of cirrhosis cognitive dysfunction is unknown. Pregnenolone sulfate (PREGS) is an excitatory neurosteroid that acts as a N-methyl-D-aspartate (NMDA) receptor agonist and GABAA receptor antagonist. In this study we evaluated the effect of intra CA1 infusion of PREGS on cirrhotic rats' memory function using the Y-maze test. Hippocampal brain-derived neurotrophic factor (BDNF) mRNA expression was also evaluated. Three weeks after bile duct ligation (BDL) surgery, rats were under stereotaxic surgery for insertion of two guide cannulas in the CA1 region of the hippocampus. After 1-week of recovery, PREGS was administered through CA1 cannulas in cirrhotic rats, while control or sham groups received vehicle. For evaluation of NMDA receptor role in memory-enhancing effects of PREGS, DL-2-Amino-5-phosphonopentanoic acid (AP5) which is a potent and competitive antagonist of NMDA receptor, co-administered with PREGS and for assessment of hippocampal BDNF mRNA expression, quantitative Real-time reverse transcriptase-PCR (RT-PCR) was used. Results showed that 28 days after BDL, cirrhotic animals' memory significantly decreased in comparison with control and sham groups, while PREGS infusion could restore memory impairment (P<0.05). PREGS effects on memory of cirrhotic rats were antagonized by DAP5. RT-PCR findings have shown that hippocampal relative BDNF mRNA expression was up-regulated in PREGS-treated groups in comparison with the BDL group (P<0.001). Our findings suggest that PREGS has a memory-enhancing effect in cirrhosis memory deficit in acute therapy and this effect may be through NMDA (glutamate) receptor involvement and BDNF mRNA expression.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , CA1 Region, Hippocampal/drug effects , CA1 Region, Hippocampal/metabolism , Liver Cirrhosis, Biliary/complications , Memory Disorders/prevention & control , Memory/drug effects , Pregnenolone/administration & dosage , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Bile Ducts/surgery , Disease Models, Animal , GABA-A Receptor Antagonists/administration & dosage , Male , Memory Disorders/complications , Memory Disorders/metabolism , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/agonists , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
5.
Hum Exp Toxicol ; 34(9): 922-31, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26286524

ABSTRACT

Accumulation of reactive oxygen species, such as hydrogen peroxide (H2O2), generated by inflammatory cells or other pathological conditions, leads to oxidative stress, which may contribute to the neuronal degeneration observed in a wide variety of neurodegenerative disorders such as Alzheimer's disease. Recent investigations have described effective properties of tropisetron, such as antiphlogistic action or protection against ß-amyloid induced-neuroinflammation in rats. Our data revealed that H2O2-induced cell death in rat pheochromocytoma cell line (PC12) can be inhibited by tropisetron, as defined by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide assay, caspase 3 and caspase 12 levels. We further showed that tropisetron exerts its protective effects by upregulation of heme oxygenase-1, glutathione, catalase activity, and nuclear factor-erythroid 2 p45-related factor 2 level. Moreover, tropisetron was recently found to be a partial agonist of α7 nicotinic acetylcholine receptor (α7nAChR). The activation of α7nAChR could inhibit inflammatory and apoptotic signaling pathways in the oxidative stress conditions. In this study, selective α7nAChR antagonists (methyllycaconitine) reversed the effects of tropisetron on caspase 3 level. Our findings indicated that tropisetron can protect PC12 cells against H2O2-induced neurotoxicity through α7nAChR in vitro.


Subject(s)
Cholinergic Agonists/pharmacology , Indoles/pharmacology , Neuroprotective Agents/pharmacology , Receptors, Serotonin, 5-HT3/drug effects , Serotonin 5-HT3 Receptor Antagonists/pharmacology , alpha7 Nicotinic Acetylcholine Receptor/drug effects , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Caspases/metabolism , Cell Death/drug effects , Cell Survival/drug effects , Hydrogen Peroxide/toxicity , Oxidative Stress/drug effects , PC12 Cells , Rats , Tropisetron
6.
Bratisl Lek Listy ; 116(1): 41-6, 2015.
Article in English | MEDLINE | ID: mdl-25666961

ABSTRACT

AIM: In the present study, the role of ethanol extract of root of Taraxacum Syriacum Boiss (TSBE) against hepatotoxicity caused by acetaminophen (APAP) was studied. METHODS: The chemical composition of roots of Taraxacum Syriacum Boiss was analyzed by SPME-GC/MS method. Hepatocellular injuries induced by acetaminophen (APAP) were assessed by liver histology, serum aminotransferase activities, antioxidant enzymes activity and lipid peroxidation in liver tissue. RESULTS: TSBE was observed to exhibit hepatoprotective effect as demonstrated by significant decrease in serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), and alkaline phosphatase (ALP) concentration, and by preventing liver histopathologic changes in rats with APAP hepatotoxicity. Administration of APAP, significantly increased, lactate dehydrogenase (LDH) and catalase (CAT) activity in liver tissue and pretreatment with TSBE returned these parameters to control group, moreover TSBE reduces APAP-induced hepatic Glutathione (GSH) depletion. Carvacrol (6.7 %) was the main polyphenolic compound of plant sample. Our results demonstrated hepatoprotective activity of TSBE in rat in vivo. CONCLUSIONS: We believe that the mechanism by which the extract was able to protect the liver from the oxidative stress generated by APAP is due to its antioxidant activity. These phenolic compounds of the extract act as antioxidants and free radical scavengers and reduce or inhibit the oxidative stress induced by APAP administration (Tab. 3, Fig. 3, Ref. 39).


Subject(s)
Acetaminophen/toxicity , Chemical and Drug Induced Liver Injury/prevention & control , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protective Agents/chemistry , Protective Agents/pharmacology , Taraxacum , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Antioxidants/pharmacology , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Ethanol , Free Radical Scavengers/pharmacology , Hepatocytes/drug effects , Lipid Peroxidation/drug effects , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar
7.
Clin Exp Dermatol ; 40(6): 647-52, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25703534

ABSTRACT

BACKGROUND: Serotonin is a pruritogenic substance in humans and animals, but the mechanisms of action through which serotonin induces itch response are not yet understood. AIM: To examine the possible role of nitric oxide (NO) in the profile of scratching behaviour due to intradermal injection of serotonin in mice. METHODS: Intradermal injection of serotonin (14.1-235 nmol per site) into the nape of the neck was used to elicit itch in mice. Scratching behaviour was evaluated by counting the number of bouts during 60 min after injection. To determine the possible involvement of the nitrergic system in serotonin-induced scratching, L-NG-nitroarginine methyl ester [L-NAME; a nonselective nitric oxide synthase (NOS) inhibitor], aminoguanidine [a selective inducible (i)NOS inhibitor] and L-arginine (an NO precursor) were administered intraperitoneally to control and serotonin-injected animals. RESULTS: Intradermal serotonin caused scratching in mice with a bell-shaped dose-response correlation, and the peak effective dose was 141 nmol per site. The majority of scratching bouts in animals occurred 5-10 min after injection. Ineffective doses of L-NAME (3 mg/kg IP) and aminoguanidine (100 mg/kg IP) decreased the scratching induced by intradermal serotonin injection in animals (P < 0.001 and P < 0.001), while an subeffective dose of L-arginine (100 mg/kg IP) augmented the scratching effect of serotonin (P < 0.001). CONCLUSIONS: We show for the first time that the scratching induced by intradermal serotonin is mediated by NOS, especially iNOS, activation. We conclude that NO may play a role in mediating itch responses. NO and NOS could be new targets for antipruritic agents.


Subject(s)
Enzyme Inhibitors , Nitric Oxide/physiology , Pruritus/chemically induced , Serotonin Receptor Agonists , Serotonin , Analysis of Variance , Animals , Arginine/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Guanidines/pharmacology , Injections, Intradermal , Male , Mice , NG-Nitroarginine Methyl Ester , Nitric Oxide Synthase/antagonists & inhibitors , Pruritus/physiopathology
8.
Acta Physiol Hung ; 101(3): 341-52, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25183508

ABSTRACT

Endoplasmic reticulum (ER) stress provides abnormalities in insulin action, inflammatory responses, lipoprotein B100 degradation and hepatic lipogenesis. Excess accumulation of triglyceride in hepatocytes may also lead to disorders such as non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Opioid peptides are involved in triglyceride and cholesterol dysregulation, inflammation and cell death. In this study, we evaluated Naltrexone effects on ER stress induced liver injury. To do so, C57/BL6 mice received saline, DMSO and Naltrexone, as control groups. ER stress was induced by tunicamycin (TM) injection. Naltrexone was given before TM administration. Liver blood flow and biochemical serum analysis were measured. Histopathological evaluations, TNF-α measurement and Real-time RT-PCR were also performed. TM challenge provokes steatosis, cellular ballooning and lobular inflammation which significantly reduced in Naltrexone treated animals. ALT, AST and TNF-α increased in the TM group and improved in the Naltrexone plus TM group. Triglyceride and cholesterol levels decreased in TM treated mice with no increase in Naltrexone treated animals. In the Naltrexone plus TM group, gene expression of Bax/Bcl-2 ratio and caspase3 significantly lowered compared with the TM group. In this study, we found that Naltrexone had a notable alleviating role in ER stress induced steatosis and liver injury.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Endoplasmic Reticulum Stress/drug effects , Endoplasmic Reticulum/drug effects , Fatty Liver/prevention & control , Liver/drug effects , Naltrexone/pharmacology , Narcotic Antagonists/pharmacology , Alanine Transaminase/blood , Animals , Anti-Inflammatory Agents/pharmacology , Aspartate Aminotransferases/blood , Biomarkers/blood , Caspase 3/metabolism , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Chemical and Drug Induced Liver Injury/physiopathology , Cholesterol/blood , Cytoprotection , Disease Models, Animal , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/pathology , Fatty Liver/chemically induced , Fatty Liver/metabolism , Fatty Liver/pathology , Fatty Liver/physiopathology , Liver/blood supply , Liver/metabolism , Liver/pathology , Liver Circulation/drug effects , Male , Mice , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease , Proto-Oncogene Proteins c-bcl-2/metabolism , Triglycerides/blood , Tumor Necrosis Factor-alpha/blood , Tunicamycin , bcl-2-Associated X Protein/metabolism
9.
Cell Mol Neurobiol ; 34(8): 1143-50, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25073869

ABSTRACT

Hyperglycemia that occurs under the diabetic condition is a major cause of diabetic complications such as diabetic neuropathy, one of the most common diabetes-related complications. It is well known that hyperglycemia could result in generation of reactive oxygen species (ROS). Over production of ROS recommended as an important mediator for apoptotic signaling pathway as well as a key early event in the development of diabetic neuropathy. Recently, many studies have indicated that lithium has robust neuroprotective effect in relation to several neurodegenerative diseases. The present study aimed to examine effects of lithium on high glucose (HG)-induced neurotoxicity and to determine some of the underlying molecular mechanisms involved in this response in PC12 cells as a neuronal culture model for diabetic neuropathy. PC12 cells were pretreated with different concentrations of lithium for 7 days, exposed to HG for 24 h. Cell viability was measured by MTT assay. ROS and lipid peroxidation levels as well as superoxide dismutase activity were measured. In order to examine the underlying molecular mechanisms, the expressions of Bax, Bcl-2, Caspase-3, total and phosphorylated JNK and P38 MAPK were also analyzed by Western blotting. The present results indicated that pretreatment with 1 mM lithium has protected PC12 cells against HG-induced apoptotic cell death. It could reduce ROS generation, Bax/Bcl-2 ratio, Caspase-3 activation, and JNK and P38 MAPK phosphorylation. It may be concluded that in HG condition, lithium pretreatment could prevent mitochondrial apoptosis as well as JNK and P38 MAPK pathway in PC12 cells.


Subject(s)
Apoptosis/drug effects , Glucose/toxicity , Lithium/pharmacology , MAP Kinase Signaling System/drug effects , Mitochondria/metabolism , Neuroprotective Agents/pharmacology , Neurotoxins/toxicity , Reactive Oxygen Species/metabolism , Animals , Caspase 3/metabolism , Cell Survival/drug effects , Enzyme Activation/drug effects , Intracellular Space/drug effects , Intracellular Space/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Lipid Peroxidation/drug effects , Mitochondria/drug effects , PC12 Cells , Phosphorylation/drug effects , Rats , Superoxide Dismutase/metabolism , bcl-2-Associated X Protein/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
10.
Auton Autacoid Pharmacol ; 34(1-2): 9-13, 2014.
Article in English | MEDLINE | ID: mdl-24674577

ABSTRACT

Considering the existence of cross-tolerance between clonidine and morphine besides the same interaction between morphine and WIN 55,212-2 persuaded us to verify this fact between WIN 55,212-2 and clonidine in guinea pig ileum, which is a well-known model to examine the mode of action of cannabinoids and α2 -adenoceptor agonists The rectangular pulses were passed to the 0.5 g stretched ileum segments that were fixed in 20-ml organ bath. PowerLab system and Graphpad Prism were applied to record twitches and analyse the data. Electrically evoked contractions were dose-dependently inhibited by WIN 55,212-2 and clonidine (pD2 = 8.56 ± 0.41 and 7.65 ± 0.15, respectively). Tolerance to this effect could be induced by 4-h incubation with WIN 55,212-2 (3 × IC50 ) (pD2  = 6.36 ± 0.26, degree of tolerance: 159.32) (P < 0.01) but not with clonidine (2 × IC50 and 4 × IC50 ) for different time courses. Dose-response curve for inhibitory action of WIN 55,212-2 was shifted to the right after 4-h incubation with clonidine (3 × 10(-10) m) comparing to the untreated tissues (pD2  = 5.26 ± 0.69, degree of tolerance: 2000) (P < 0.001). This observation provides the evidence for the cannabinoid-noradrenergic systems interaction in the enteric nervous system as a simplified representative for central nervous system.


Subject(s)
Benzoxazines/antagonists & inhibitors , Benzoxazines/pharmacology , Clonidine/pharmacology , Drug Tolerance , Enteric Nervous System/drug effects , Ileum/drug effects , Morpholines/antagonists & inhibitors , Morpholines/pharmacology , Naphthalenes/antagonists & inhibitors , Naphthalenes/pharmacology , Animals , Dose-Response Relationship, Drug , Electric Stimulation , Enteric Nervous System/physiology , Guinea Pigs , Ileum/physiology , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology
11.
Neuroscience ; 248: 299-306, 2013 Sep 17.
Article in English | MEDLINE | ID: mdl-23774631

ABSTRACT

Tropisetron, a selective 5-HT3 receptor (5-HT3R) antagonist, has been widely used to counteract chemotherapy-induced emesis. New investigations described the immunomodulatory properties of tropisetron which may not be 5HT3R mediated. In the present study, we assessed the potential effects of tropisetron on an animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). EAE was induced in C57BL/6 mice by myelin oligodendrocyte glycoprotein peptide (MOG35-55) immunization. Animals were treated with tropisetron (5 mg/kg/day); m-chlorophenylbiguanide (mCPBG), a selective 5-HT3R agonist (10 mg/kg/day); tropisetron (5 mg/kg/day) plus mCPBG (10 mg/kg/day), and granisetron (5 mg/kg/day) intraperitoneally on days 3-35 post-immunization. Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0.001) and reduced leukocyte infiltration as well as demyelination in the spinal cord (p<0.05). In addition, in vivo tropisetron, granisetron or tropisetron plus mCPBG therapy greatly reduced in vitro MOG35-55-stimulated proliferation of mononuclear cells from spleens, and MOG35-55-induced IL-2, IL-6 and IL-17 production by splenocytes isolated from EAE-induced mice (p<0.05). Concurrent administration of tropisetron and mCPBG did not significantly alter the histological damage in the spinal cord. mCPBG had no effect on the mentioned parameters. Taken together, these findings indicate that tropisetron has considerable immunoregulatory functions in EAE and may be promising for the treatment of MS or other autoimmune and inflammatory diseases of the CNS. Furthermore, beneficial effects of tropisetron in this setting seem to be both receptor dependent and receptor independent in the early phase of the disease.


Subject(s)
Cell Proliferation/drug effects , Demyelinating Diseases/drug therapy , Encephalomyelitis, Autoimmune, Experimental/immunology , Indoles/pharmacology , Leukocytes, Mononuclear/drug effects , Multiple Sclerosis/drug therapy , Animals , Biguanides/administration & dosage , Biguanides/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Therapy, Combination , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/metabolism , Granisetron/administration & dosage , Granisetron/pharmacology , Indoles/administration & dosage , Leukocytes, Mononuclear/cytology , Mice , Mice, Inbred C57BL , Multiple Sclerosis/etiology , Multiple Sclerosis/pathology , Receptors, Serotonin, 5-HT3/drug effects , Serotonin 5-HT3 Receptor Agonists/administration & dosage , Serotonin 5-HT3 Receptor Agonists/pharmacology , Serotonin 5-HT3 Receptor Antagonists/administration & dosage , Serotonin 5-HT3 Receptor Antagonists/pharmacology , Spinal Cord/drug effects , Spinal Cord/pathology , Spleen/cytology , Treatment Outcome , Tropisetron
12.
Eur J Obstet Gynecol Reprod Biol ; 168(2): 161-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23398725

ABSTRACT

OBJECTIVES: To investigate the effect of morphine on the reduced uteroplacental perfusion pressure (RUPP) model of pre-eclampsia in rats. STUDY DESIGN: The abdominal aorta and ovarian arteries of pregnant rats were isolated and clipped on gestational day 14. The chronic morphine treatment group received naltrexone 5 mg/kg 1h before each dose of morphine. L-nitromonomethylarginine 2 mg/kg was administrated in the same pattern. The control group received saline 10 ml/kg. Systolic blood pressure, blood urea nitrogen (BUN), creatinine, creatinine clearance, urinary protein, urinary nitrite/nitrate excretion, and fetal and placental weights were determined. RESULTS: Morphine significantly reduced systolic blood pressure, fetal and placental weights, plasma BUN, creatinine and urinary protein in RUPP rats compared with control rats. Urinary nitrite/nitrate excretion and creatinine clearance were significantly increased in response to morphine treatment. CONCLUSION: Morphine reduced blood pressure and improved renal function in the RUPP model of pre-eclampsia, but this was associated with reduced fetal and placental weights.


Subject(s)
Antihypertensive Agents/therapeutic use , Disease Models, Animal , Morphine/therapeutic use , Nitric Oxide/metabolism , Placental Circulation/drug effects , Pre-Eclampsia/drug therapy , Receptors, Opioid, mu/agonists , Animals , Antihypertensive Agents/adverse effects , Antihypertensive Agents/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Female , Fetal Development/drug effects , Kidney/drug effects , Kidney/metabolism , Kidney/physiopathology , Morphine/adverse effects , Morphine/antagonists & inhibitors , Narcotic Antagonists/pharmacology , Nitrates/urine , Nitric Oxide Synthase/antagonists & inhibitors , Nitrites/urine , Placentation/drug effects , Pre-Eclampsia/metabolism , Pre-Eclampsia/physiopathology , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, Opioid, mu/antagonists & inhibitors , Renal Insufficiency/etiology , Renal Insufficiency/prevention & control , Up-Regulation/drug effects
13.
Arzneimittelforschung ; 62(12): 650-4, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23196970

ABSTRACT

Nicotine, the main pharmacologically active component in tobacco and cigarette, has some toxic effects and also high potential for addiction. In this study, the effect of artichoke (Cynara scolymus L.) and zeolite nano-materials on urinary excretion of nicotine and consequently elimination of systematically absorbed nicotine was investigated. A simple, valid and highly sensitive high performance liquid chromatography method has been developed for determination of nicotine in rat urine according to guidelines for bioanalysis.It was found that nano-zeolites can cause increase in urinary concentration of nicotine due to its high surface adsorption. Artichoke leaf extract can cause increase in urinary excretion of nicotine in longer post administration times. It was observed that co-administration of nanozeolites and the leaf extract has the synergetic effect on increasing the urinary excretion of nicotine.


Subject(s)
Cynara scolymus/chemistry , Nicotine/pharmacokinetics , Nicotinic Agonists/pharmacokinetics , Zeolites/pharmacology , Animals , Calibration , Chromatography, High Pressure Liquid , Indicators and Reagents , Limit of Detection , Nanoparticles , Nicotine/urine , Nicotinic Agonists/urine , Plant Extracts/pharmacology , Plant Leaves/chemistry , Rats , Rats, Wistar , Reproducibility of Results
14.
Reprod Sci ; 18(6): 545-50, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21285452

ABSTRACT

BACKGROUND AND PURPOSE: The sperm of infertile men with varicocele exhibit markedly high DNA damage that appears to be related to high oxidative stress (OS). Aminoguanidine (AG) is a specific inhibitor of the nitric oxide synthase (NOS) isoforms iNOS and an antioxidant, the effects of which decrease NO and peroxynitrite production. The aim of this study was to determine the effects of AG on sperm chromatin in varicocelized rats. METHODS: Thirty male Wistar rats were divided into 5 groups: control, sham, varicocele, and AG and placebo-treated groups. At 10 weeks after varicocele induction, sperm chromatin was evaluated in all groups, except in the treated groups. The treated groups received intraperitoneal injections of 50 mg/kg AG or placebo daily for 10 weeks and then were killed for chromatin assessment. Sperm chromatin was evaluated by aniline blue, acridine orange, toluidine blue, and chromomycin A(3) staining. RESULTS: The results of the 4 above tests were significantly increased between varicocele and control (and sham) groups (P < .05). CONCLUSION: The findings of this study suggest that AG improves sperm DNA fragmentation that is associated with infertility in varicocelized rats, and treatment with AG can reduce the damage to sperm DNA.


Subject(s)
DNA Fragmentation/drug effects , Enzyme Inhibitors/therapeutic use , Guanidines/therapeutic use , Infertility, Male/drug therapy , Nitric Oxide/physiology , Spermatozoa/drug effects , Animals , Chromatin/drug effects , Infertility, Male/etiology , Male , Nitric Oxide/antagonists & inhibitors , Nitric Oxide Synthase Type II/antagonists & inhibitors , Rats , Rats, Wistar , Varicocele/complications
15.
Urol Int ; 86(3): 302-6, 2011.
Article in English | MEDLINE | ID: mdl-21088382

ABSTRACT

INTRODUCTION: Increased levels of nitric oxide (NO) in the spermatic veins of men affected by varicocele have already been reported. But there is no study to discriminate the subtype of catalytic enzyme for synthesis of NO. In this study, aminoguanidine (AG), an inducible NO synthase inhibitor, has been used to investigate its effect on sperm parameters. METHODS: Twenty-four male Wistar rats were divided into four groups. In groups A and B, left experimental varicocele was induced by a 20-gauge needle. Group C (sham) underwent a similar procedure to groups A and B, but the spermatic vein was left intact, and group D served as control group. The animals in group A were killed 10 weeks later and their sperm count, motility, morphology and vitality were evaluated. Group B received 50 mg/kg AG with i.p. injection daily for 10 weeks. RESULTS: Sperm count, motility, morphology and vitality were significantly decreased in group A in comparison to control group (p ≤ 0.05). In group B, sperm parameters improved in comparison to group A (p ≤ 0.01). Group C did not show any significant alterations in sperm parameters compared with control group. CONCLUSION: These findings may support the concept that AG can improve the sperm count, motility, morphology and vitality in infertile rats with varicocele.


Subject(s)
Epididymis/drug effects , Guanidines/pharmacology , Varicocele/drug therapy , Animals , Enzyme Inhibitors/pharmacology , Female , Infertility, Male/pathology , Male , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Rats, Wistar , Reactive Oxygen Species , Sperm Motility , Spermatozoa/pathology , Testis/blood supply
16.
J Psychopharmacol ; 24(4): 585-94, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19351802

ABSTRACT

Although there is evidence of the involvement of N-methyl-D-aspartate receptors (NMDAR) in the action of lithium, its role in the antidepressant effects of lithium in a behavioural model remains unclear. In this study, we evaluated the effects of NMDAR antagonists on the antidepressant-like effects of lithium in the mouse forced swimming test. Lithium (30 and 100 mg/kg, i.p.) significantly (P < 0.01) reduced the immobility times of mice, whereas at lower doses (5 and 10 mg/kg) had no effect. NMDA antagonists ketamine (2 and 5 mg/kg, i.p.), MK-801 (0.1 and 0.25 mg/kg, i.p.) and ifenprodil (1 and 3 mg/kg, i.p.) significantly (P < 0.05) decreased the immobility time. Lower doses of ketamine (0.5 and 1 mg/kg), MK-801 (0.01 and 0.05 mg/kg) and ifenprodil (0.1 and 0.5 mg/kg) had no effect. Combined treatment of subeffective doses of lithium (10 mg/kg) and ketamine (1 mg/kg), MK-801 (0.05 mg/kg) or ifenprodil (0.5 mg/kg) robustly (P < 0.001) exerted an antidepressant-like effect. The noneffective dose of a NMDA agonist (NMDA, 75 mg/kg, i.p.) prevented the antidepressant-like effect of lithium (30 mg/kg). None of the drugs at subactive doses or in combination with lithium had significant effect on the locomotor activity in the open field test. We for the first time suggested a role for NMDAR signalling in the antidepressant-like effects of lithium, providing a new approach for treatment of depression.


Subject(s)
Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Lithium Chloride/pharmacology , Motor Activity/drug effects , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Swimming , Animals , Antidepressive Agents/administration & dosage , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Excitatory Amino Acid Agonists/pharmacology , Injections, Intraperitoneal , Ketamine/pharmacology , Lithium Chloride/administration & dosage , Male , Mice , Models, Animal , N-Methylaspartate/pharmacology , Piperidines/pharmacology , Time Factors
17.
Toxicol Appl Pharmacol ; 232(1): 119-24, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18671992

ABSTRACT

Type 1 diabetes is an autoimmune disease characterized by inflammation of pancreatic islets and destruction of beta cells by the immune system. Opioids have been shown to modulate a number of immune functions, including T helper 1 (Th1) and T helper 2 (Th2) cytokines. The immunosuppressive effect of long-term administration of opioids has been demonstrated both in animal models and humans. The aim of this study was to determine the effect of methadone, a mu-opioid receptor agonist, on type 1 diabetes. Administration of multiple low doses of streptozotocin (STZ) (MLDS) (40 mg/kg intraperitoneally for 5 consecutive days) to mice resulted in autoimmune diabetes. Mice were treated with methadone (10 mg/kg/day subcutaneously) for 24 days. Blood glucose, insulin and pancreatic cytokine levels were measured. Chronic methadone treatment significantly reduced hyperglycemia and incidence of diabetes, and restored pancreatic insulin secretion in the MLDS model. The protective effect of methadone can be overcome by pretreatment with naltrexone, an opioid receptor antagonist. Also, methadone treatment decreased the proinflammatory Th1 cytokines [interleukin (IL)-1beta, tumor necrosis factor-alpha and interferon-gamma] and increased anti-inflammatory Th2 cytokines (IL-4 and IL-10). Histopathological observations indicated that STZ-mediated destruction of beta cells was attenuated by methadone treatment. It seems that methadone as an opioid agonist may have a protective effect against destruction of beta cells and insulitis in the MLDS model of type 1 diabetes.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Hypoglycemic Agents/pharmacology , Immunosuppressive Agents/pharmacology , Methadone/pharmacology , Pancreas/drug effects , Receptors, Opioid, mu/agonists , Animals , Blood Glucose/drug effects , Cytokines/metabolism , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/metabolism , Drug Administration Schedule , Injections, Intraperitoneal , Insulin/blood , Mice , Naltrexone/pharmacology , Narcotic Antagonists/pharmacology , Pancreas/immunology , Pancreas/metabolism , Pancreas/pathology , Receptors, Opioid, mu/metabolism , Streptozocin/administration & dosage , Time Factors
18.
Br J Pharmacol ; 151(5): 591-601, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17486141

ABSTRACT

BACKGROUND AND PURPOSE: Relaxation of corpus cavernosum, which is mediated by nitric oxide (NO) released from non-adrenergic non-cholinergic (NANC) neurotransmission, is critical for inducing penile erection and can be affected by many pathophysiological conditions. However, the peripheral effect of liver cirrhosis on erectile function is as yet unknown. The aim of the present study was to investigate the effect of biliary cirrhosis on NANC-mediated relaxation of rat corpus cavernosum and the possible roles of endocannabinoid and nitric oxide systems in this model. EXPERIMENTAL APPROACH: Cirrhosis was induced by bile duct ligation. Controls underwent sham operation. Four weeks later, strips of corpus cavernosum were mounted in a standard organ bath and NANC-mediated relaxations were obtained by applying electrical field stimulation. KEY RESULTS: The NANC-mediated relaxation was enhanced in corporal strips from cirrhotic animals. Anandamide potentiated the relaxations in both groups. Either AM251 (CB(1) antagonist) or capsazepine (vanilloid VR(1) antagonist), but not AM630 (CB(2) antagonist), prevented the enhanced relaxations of cirrhotic strips. Either the non-selective NOS inhibitor L-NAME or the selective neuronal NOS inhibitor L-NPA inhibited relaxations in both groups, but cirrhotic groups were more resistant to the inhibitory effects of these agents. Relaxations to sodium nitroprusside (NO donor) were similar in tissues from the two groups. CONCLUSIONS AND IMPLICATIONS: Cirrhosis potentiates the neurogenic relaxation of rat corpus cavernosum probably via the NO pathway and involving cannabinoid CB(1) and vanilloid VR(1) receptors.


Subject(s)
Cannabinoid Receptor Modulators/physiology , Endocannabinoids , Liver Cirrhosis, Biliary/physiopathology , Nitric Oxide/physiology , Penis/physiopathology , Signal Transduction/physiology , Animals , Arachidonic Acids/pharmacology , Arginine/analogs & derivatives , Arginine/pharmacology , Blotting, Western , Cannabinoids/pharmacology , Electric Stimulation , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Male , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type I/metabolism , Nitroprusside/pharmacology , Penis/innervation , Phenylephrine/pharmacology , Polyunsaturated Alkamides/pharmacology , Rats , TRPV Cation Channels/antagonists & inhibitors , Vasoconstrictor Agents/pharmacology
19.
Br J Pharmacol ; 149(7): 898-908, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17043671

ABSTRACT

BACKGROUND AND PURPOSE: Hyperdynamic circulation and mesenteric hyperaemia are found in cirrhosis. To delineate the role of endocannabinoids in these changes, we examined the cardiovascular effects of anandamide, AM251 (CB(1) antagonist), AM630 (CB(2) antagonist) and capsazepine (VR1 antagonist), in a rat model of cirrhosis. EXPERIMENTAL APPROACH: Cirrhosis was induced by bile duct ligation. Controls underwent sham operation. Four weeks later, diameters of mesenteric arteriole and venule (intravital microscopy), arterial pressure, cardiac output, systemic vascular resistance and superior mesenteric artery (SMA) flow were measured after anandamide, AM251 (with or without anandamide), AM630 and capsazepine administration. CB(1), CB(2) and VR1 receptor expression in SMA was assessed by western blot and RT-PCR. KEY RESULTS: Anandamide increased mesenteric vessel diameter and flow, and cardiac output in cirrhotic rats, but did not affect controls. Anandamide induced a triphasic arterial pressure response in controls, but this pattern differed markedly in cirrhotic rats. Pre-administration of AM251 blocked the effects of anandamide. AM251 (without anandamide) increased arterial pressure and systemic vascular resistance, constricted mesenteric arterioles, decreased SMA flow and changed cardiac output in a time-dependent fashion in cirrhotic rats. Capsazepine decreased cardiac output and mesenteric arteriolar diameter and flow, and increased systemic vascular resistance in cirrhotic rats, but lacked effect in controls. Expression of CB(1) and VR1 receptor proteins were increased in cirrhotic rats. AM630 did not affect any cardiovascular parameter in either group. CONCLUSIONS AND IMPLICATIONS: These data suggest that endocannabinoids contribute to hyperdynamic circulation and mesenteric hyperaemia in cirrhosis, via CB(1)- and VR1-mediated mechanisms.


Subject(s)
Arachidonic Acids/pharmacology , Hyperemia/physiopathology , Liver Cirrhosis, Biliary/physiopathology , Polyunsaturated Alkamides/pharmacology , Receptor, Cannabinoid, CB1/drug effects , Splanchnic Circulation/drug effects , TRPV Cation Channels/drug effects , Vasodilator Agents/pharmacology , Animals , Bile Ducts/surgery , Blood Flow Velocity , Blood Pressure/drug effects , Blotting, Western , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Cardiac Output/drug effects , Disease Models, Animal , Endocannabinoids , Hyperemia/etiology , Hyperemia/metabolism , Indoles/pharmacology , Liver Circulation/drug effects , Liver Cirrhosis, Biliary/complications , Liver Cirrhosis, Biliary/metabolism , Male , Mesenteric Artery, Superior/chemistry , Mesenteric Artery, Superior/drug effects , Piperidines/pharmacology , Pyrazoles/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptor, Cannabinoid, CB1/analysis , Receptor, Cannabinoid, CB1/metabolism , Receptor, Cannabinoid, CB2/drug effects , Reverse Transcriptase Polymerase Chain Reaction , TRPV Cation Channels/analysis , TRPV Cation Channels/metabolism , Time Factors , Vascular Resistance/drug effects , Vasodilation/drug effects
20.
Pharmazie ; 61(7): 625-30, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16889071

ABSTRACT

In this study, the effects of two different calcium channel blockers, diltiazem and verapamil on calcium uptake and release from the membrane of heavy sarcoplasmic reticulum (SR) of chicken skeletal muscle were investigated. A fluorescent chelate probe technique was employed to determine calcium movement through the SR. Chlortetracycline was used as a fluorescent indicator which is able to penetrate the membrane, bind to the calcium on the inner face of the membrane and show an increase in fluorescence intensity when calcium uptake occurs. Addition of tris-ATP to the microsomes caused ATP-induced calcium uptake in a concentration dependent manner with half-maximal calcium uptake around 0.126 mM. Pretreatment of the medium containing sarcoplasmic reticulum with different concentrations of diltiazem or verapamil followed by added tris-ATP resulted a significant decrease in the fluorescence intensity of chlortetracycline, showing that these calcium channel blockers can diminish ATP-induced calcium uptake in a concentration-dependent manner. The maximum fluorescence intensity of tris-ATP falls to 50% in the presence of 1.75 microM diltiazem and 25 nM verapamil. In addition, diltiazem and verapamil can significantly induce rapid calcium release from the membrane of sarcoplasmic reticulum in a concentration-dependent manner. Therefore, membrane-bound or sequestered calcium in the sarcoplasmic reticulum may be targeted by these two calcium channel blockers in chicken skeletal muscle. Chicken SR is about 1000 times more sensitive to the effects of diltiazem on Ca2+ uptake and release than rabbit SR as shown previously.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium/metabolism , Chickens/metabolism , Diltiazem/pharmacology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Sarcoplasmic Reticulum/metabolism , Verapamil/pharmacology , Adenosine Triphosphate/physiology , Animals , Anti-Bacterial Agents/metabolism , Chlortetracycline/metabolism , Fluorescent Dyes , In Vitro Techniques , Microscopy, Fluorescence , Sarcoplasmic Reticulum/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...